The power of choice: Why patient optionality is the key to advancing clinical research
This whitepaper explores the significance of the patient optionality evolution in clinical trials, including its ability to overcome longstanding barriers to clinical trial participation and address the need for more diverse representation in research.
As the trend for conducting studies outside of the traditional site continues, we are beginning to see a future where sponsors can offer participants a range of visit model options, from mobile clinicians to community sites. This whitepaper explores the significance of this evolution, including its ability to overcome longstanding barriers to clinical trial participation and address the need for more diverse representation in research. It will also discuss the burgeoning landscape for hybrid trial participation models and provide advice for how sponsors can take the next step in implementing participant optionality in trials.
//
(SizeLimitingPyMap: {content_type__c=Whitepaper, ns_company__c=PCM Trials, ns_whitepaper_name__c=The power of choice: Why patient optionality is the key to advancing clinical research, permutive_id__c=, referrer_url=, utm_campaign__c=, utm_medium__c=, verdict_company_email__c=leads@verdict.co.uk,josh.jones@globaldata.com,hannan.anwar@globaldata.com,Andy.Eckles@procasemanagement.com,trish.joyce@procasemanagement.com,joe.roberts@verdict.co.uk, verdict_marketing_opt_in__c=, verdict_privacy_opt_in__c=true, vms_company_name__c=PCM Trials, vms_form=Whitepaper, vms_post_id__c=ELP The power of choice: Why patient optionality is the key to advancing clinical research , vms_site_id__c=22, vms_site_logo__c=https://www.clinicaltrialsarena.com/wp-content/themes/goodlife-wp/assets/images/logo.png, vms_site_name=Clinical Trials Arena, vms_title__c=The power of choice: Why patient optionality is the key to advancing clinical research, vms_title_multiple__c=, vms_whitepaper_url__c=https://live-b2b-gdm-figaro1.pantheonsite.io/wp-content/uploads/sites/22/2024/12/PCM_The-power-of-choice-Why-patient-optionality-is-the-key-to-advancing-clinical-research.pdf})
Enter your details below to receive your free whitepaper
By clicking the Submit button, you acknowledge that GlobalData may share your information with PCM Trials and that your personal data will be used as described in their Privacy Policy.
We will also collect and use the information you provide for carefully considered and specific purposes, where we believe we have a legitimate interest in doing so, for example to send you communications about similar products and services we offer. We will always give you an option to opt out of any future communications from us. You can find out more about our legitimate interest activity in our privacy policy here. ‘We’ includes Verdict Media Limited and other GlobalData brands as detailed here.
